Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated:  10/13/2015
CCOP - Grand Rapids
mi
from
Grand Rapids, MI
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated: 10/13/2015
CCOP - Grand Rapids
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated:  10/13/2015
CCOP - Metro-Minnesota
mi
from
St. Louis Park, MN
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated: 10/13/2015
CCOP - Metro-Minnesota
mi
from
St. Louis Park, MN
Click here to add this to my saved trials
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated:  10/13/2015
CCOP - Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated: 10/13/2015
CCOP - Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated:  10/13/2015
CCOP - Hematology-Oncology Associates of Central New York
mi
from
East Syracuse, NY
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated: 10/13/2015
CCOP - Hematology-Oncology Associates of Central New York
mi
from
East Syracuse, NY
Click here to add this to my saved trials
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated:  10/13/2015
CCOP - North Shore University Hospital
mi
from
Manhasset, NY
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated: 10/13/2015
CCOP - North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated:  10/13/2015
CCOP - Southeast Cancer Control Consortium
mi
from
Winston-Salem, NC
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated: 10/13/2015
CCOP - Southeast Cancer Control Consortium
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated:  10/13/2015
CCOP - Columbia River Oncology Program
mi
from
Portland, OR
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated: 10/13/2015
CCOP - Columbia River Oncology Program
mi
from
Portland, OR
Click here to add this to my saved trials
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated:  10/13/2015
CCOP - Greenville
mi
from
Greenville, SC
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated: 10/13/2015
CCOP - Greenville
mi
from
Greenville, SC
Click here to add this to my saved trials
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated:  10/13/2015
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated: 10/13/2015
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated:  10/13/2015
CCOP - Virginia Mason Research Center
mi
from
Seattle, WA
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated: 10/13/2015
CCOP - Virginia Mason Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated:  10/13/2015
CCOP - Northwest
mi
from
Tacoma, WA
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated: 10/13/2015
CCOP - Northwest
mi
from
Tacoma, WA
Click here to add this to my saved trials
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated:  10/13/2015
CCOP - Marshfield Clinic Research Foundation
mi
from
Marshfield, WI
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)
Status: Enrolling
Updated: 10/13/2015
CCOP - Marshfield Clinic Research Foundation
mi
from
Marshfield, WI
Click here to add this to my saved trials
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  10/13/2015
MBCCOP - Hawaii
mi
from
Honolulu, HI
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 10/13/2015
MBCCOP - Hawaii
mi
from
Honolulu, HI
Click here to add this to my saved trials
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  10/13/2015
CCOP - Central Illinois
mi
from
Decatur, IL
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 10/13/2015
CCOP - Central Illinois
mi
from
Decatur, IL
Click here to add this to my saved trials
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  10/13/2015
CCOP - Evanston
mi
from
Evanston, IL
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 10/13/2015
CCOP - Evanston
mi
from
Evanston, IL
Click here to add this to my saved trials
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  10/13/2015
CCOP - Wichita
mi
from
Wichita, KA
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 10/13/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  10/13/2015
CCOP - Grand Rapids
mi
from
Grand Rapids, MI
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 10/13/2015
CCOP - Grand Rapids
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  10/13/2015
CCOP - Metro-Minnesota
mi
from
St. Louis Park, MN
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 10/13/2015
CCOP - Metro-Minnesota
mi
from
St. Louis Park, MN
Click here to add this to my saved trials
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  10/13/2015
CCOP - Kansas City
mi
from
Kansas City, MO
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 10/13/2015
CCOP - Kansas City
mi
from
Kansas City, MO
Click here to add this to my saved trials
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  10/13/2015
CCOP - Hematology-Oncology Associates of Central New York
mi
from
Syracuse, NY
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 10/13/2015
CCOP - Hematology-Oncology Associates of Central New York
mi
from
Syracuse, NY
Click here to add this to my saved trials
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  10/13/2015
CCOP - Southeast Cancer Control Consortium
mi
from
Goldsboro, NC
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 10/13/2015
CCOP - Southeast Cancer Control Consortium
mi
from
Goldsboro, NC
Click here to add this to my saved trials
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  10/13/2015
CCOP - Columbus
mi
from
Columbus, OH
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 10/13/2015
CCOP - Columbus
mi
from
Columbus, OH
Click here to add this to my saved trials
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  10/13/2015
CCOP - Dayton
mi
from
Dayton, OH
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 10/13/2015
CCOP - Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  10/13/2015
CCOP - Greenville
mi
from
Greenville, SC
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 10/13/2015
CCOP - Greenville
mi
from
Greenville, SC
Click here to add this to my saved trials
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  10/13/2015
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 10/13/2015
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  10/13/2015
CCOP - Virginia Mason Research Center
mi
from
Seattle, WA
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 10/13/2015
CCOP - Virginia Mason Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  10/13/2015
CCOP - Northwest
mi
from
Tacoma, WA
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 10/13/2015
CCOP - Northwest
mi
from
Tacoma, WA
Click here to add this to my saved trials
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated:  10/13/2015
CCOP - Marshfield Clinic Research Foundation
mi
from
Marshfield, WI
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Status: Enrolling
Updated: 10/13/2015
CCOP - Marshfield Clinic Research Foundation
mi
from
Marshfield, WI
Click here to add this to my saved trials
Aerobic Exercise, Resistance Exercise, or Flexibility and Relaxation Training in Inactive Older Female Breast Cancer Survivors
Comparison of Aerobic and Resistance Exercise in Older Breast Cancer Survivors
Status: Enrolling
Updated:  10/13/2015
Knight Cancer Institute at Oregon Health and Science University
mi
from
Portland, OR
Aerobic Exercise, Resistance Exercise, or Flexibility and Relaxation Training in Inactive Older Female Breast Cancer Survivors
Comparison of Aerobic and Resistance Exercise in Older Breast Cancer Survivors
Status: Enrolling
Updated: 10/13/2015
Knight Cancer Institute at Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
CMT-07-08: The PROstate Bed Evaluation Study
The Probe Study - The PROstate Bed Evaluation - A Study to Record the Implant Experience, Transponder Stability and Tracking Data of the Calypso 4D Localization Study in the Prostate Bed
Status: Enrolling
Updated:  10/13/2015
21C Oncology - Scottsdale
mi
from
Scottsdale, AZ
CMT-07-08: The PROstate Bed Evaluation Study
The Probe Study - The PROstate Bed Evaluation - A Study to Record the Implant Experience, Transponder Stability and Tracking Data of the Calypso 4D Localization Study in the Prostate Bed
Status: Enrolling
Updated: 10/13/2015
21C Oncology - Scottsdale
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
CMT-07-08: The PROstate Bed Evaluation Study
The Probe Study - The PROstate Bed Evaluation - A Study to Record the Implant Experience, Transponder Stability and Tracking Data of the Calypso 4D Localization Study in the Prostate Bed
Status: Enrolling
Updated:  10/13/2015
Metropolitan Uro-Rad
mi
from
St. Louis, MO
CMT-07-08: The PROstate Bed Evaluation Study
The Probe Study - The PROstate Bed Evaluation - A Study to Record the Implant Experience, Transponder Stability and Tracking Data of the Calypso 4D Localization Study in the Prostate Bed
Status: Enrolling
Updated: 10/13/2015
Metropolitan Uro-Rad
mi
from
St. Louis, MO
Click here to add this to my saved trials
Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer
A Quality of Life Study for Patients With Primary or Metastatic Liver Cancer Who Are Treated With Radioembolization (Y90 Microspheres) or Transcatheter Arterial Embolization (TACE)
Status: Enrolling
Updated:  10/14/2015
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
mi
from
Chicago, IL
Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer
A Quality of Life Study for Patients With Primary or Metastatic Liver Cancer Who Are Treated With Radioembolization (Y90 Microspheres) or Transcatheter Arterial Embolization (TACE)
Status: Enrolling
Updated: 10/14/2015
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
A Randomized Open-Label Multi-Institution Phase II Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)
Status: Enrolling
Updated:  10/14/2015
California Pacific Medical Center
mi
from
San Francisco, CA
Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
A Randomized Open-Label Multi-Institution Phase II Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)
Status: Enrolling
Updated: 10/14/2015
California Pacific Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
A Randomized Open-Label Multi-Institution Phase II Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)
Status: Enrolling
Updated:  10/14/2015
Columbia University, New York - Presbyterian Hospital
mi
from
New York, NY
Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
A Randomized Open-Label Multi-Institution Phase II Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)
Status: Enrolling
Updated: 10/14/2015
Columbia University, New York - Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
A Randomized Open-Label Multi-Institution Phase II Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)
Status: Enrolling
Updated:  10/14/2015
Hollings Cancer Center at Medical University of South Carolina
mi
from
Charleston, SC
Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
A Randomized Open-Label Multi-Institution Phase II Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)
Status: Enrolling
Updated: 10/14/2015
Hollings Cancer Center at Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
A Randomized Open-Label Multi-Institution Phase II Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)
Status: Enrolling
Updated:  10/14/2015
UVA Cancer Center
mi
from
Charlottesville, VA
Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
A Randomized Open-Label Multi-Institution Phase II Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)
Status: Enrolling
Updated: 10/14/2015
UVA Cancer Center
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
A Randomized Open-Label Multi-Institution Phase II Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)
Status: Enrolling
Updated:  10/14/2015
USC/Norris Comprehensive Cancer Center and Hospital
mi
from
Los Angeles, CA
Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
A Randomized Open-Label Multi-Institution Phase II Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)
Status: Enrolling
Updated: 10/14/2015
USC/Norris Comprehensive Cancer Center and Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
A Randomized Open-Label Multi-Institution Phase II Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)
Status: Enrolling
Updated:  10/14/2015
Tennessee Oncology, PLLCat Sarah Cannon Cancer Center
mi
from
Nashville, TN
Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
A Randomized Open-Label Multi-Institution Phase II Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)
Status: Enrolling
Updated: 10/14/2015
Tennessee Oncology, PLLCat Sarah Cannon Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors
A Phase 1b/2a Study of ABT-888 in Combination With Bendamustine +/- Rituximab in Lymphoma, Multiple Myeloma and Solid Tumors
Status: Enrolling
Updated:  10/14/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors
A Phase 1b/2a Study of ABT-888 in Combination With Bendamustine +/- Rituximab in Lymphoma, Multiple Myeloma and Solid Tumors
Status: Enrolling
Updated: 10/14/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer
Phase II Open Label Non-Randomized Single Agent Study of the SMAC (Second Mitochondrial-Derived Activator of Caspases)-Mimetic Birinapant (TL32711; NSC 756502) in Relapsed Platinum Resistant or Refractory Epithelial Ovarian Cancer, Primary Peritoneal
Status: Enrolling
Updated:  10/14/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer
Phase II Open Label Non-Randomized Single Agent Study of the SMAC (Second Mitochondrial-Derived Activator of Caspases)-Mimetic Birinapant (TL32711; NSC 756502) in Relapsed Platinum Resistant or Refractory Epithelial Ovarian Cancer, Primary Peritoneal
Status: Enrolling
Updated: 10/14/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Scripps Polster Breast Care Center Investigational GeneBank
Scripps Polster Breast Care Center Investigational GeneBank
Status: Enrolling
Updated:  10/14/2015
Scripps Polster Breast Care Center
mi
from
La Jolla, CA
Scripps Polster Breast Care Center Investigational GeneBank
Scripps Polster Breast Care Center Investigational GeneBank
Status: Enrolling
Updated: 10/14/2015
Scripps Polster Breast Care Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast Cancer
A Phase II Study: Irinotecan and Etoposide as Treatment for Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated:  10/15/2015
Arizona Cancer Center at University of Arizona Health Sciences Center
mi
from
Tucson, AZ
Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast Cancer
A Phase II Study: Irinotecan and Etoposide as Treatment for Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated: 10/15/2015
Arizona Cancer Center at University of Arizona Health Sciences Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Phase IB Intravesical Administration of SCH 721015
Phase 1B Intravesical Administration of SCH 721015 (Ad-IFNa) in Admixture With SCH 209702 (Syn3) for The Treatment of BCG Refractory Superficial Bladder Cancer
Status: Enrolling
Updated:  10/15/2015
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Phase IB Intravesical Administration of SCH 721015
Phase 1B Intravesical Administration of SCH 721015 (Ad-IFNa) in Admixture With SCH 209702 (Syn3) for The Treatment of BCG Refractory Superficial Bladder Cancer
Status: Enrolling
Updated: 10/15/2015
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
RO4929097 in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Recently Completed Treatment With Front-Line Chemotherapy
Phase II/Pharmacodynamic Study of the γ-secretase Inhibitor RO4929097 in Patients Who Have Recently Completed Front-Line Chemotherapy for Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated:  10/15/2015
M D Anderson Cancer Center
mi
from
Houston, TX
RO4929097 in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Recently Completed Treatment With Front-Line Chemotherapy
Phase II/Pharmacodynamic Study of the γ-secretase Inhibitor RO4929097 in Patients Who Have Recently Completed Front-Line Chemotherapy for Advanced Non-small Cell Lung Cancer
Status: Enrolling
Updated: 10/15/2015
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
S0927: Omega-3-Fatty Acid Supplements in Treating Muscle and Bone Pain and Stiffness in Pts W/Stage I, II, or III Breast Cancer Receiving Hormone Therapy
S0927: A Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain and Stiffness In Women With Early Stage Breast Cancer, Phase III
Status: Enrolling
Updated:  10/15/2015
Providence Cancer Center at Providence Hospital
mi
from
Mobile, AL
S0927: Omega-3-Fatty Acid Supplements in Treating Muscle and Bone Pain and Stiffness in Pts W/Stage I, II, or III Breast Cancer Receiving Hormone Therapy
S0927: A Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain and Stiffness In Women With Early Stage Breast Cancer, Phase III
Status: Enrolling
Updated: 10/15/2015
Providence Cancer Center at Providence Hospital
mi
from
Mobile, AL
Click here to add this to my saved trials
S0927: Omega-3-Fatty Acid Supplements in Treating Muscle and Bone Pain and Stiffness in Pts W/Stage I, II, or III Breast Cancer Receiving Hormone Therapy
S0927: A Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain and Stiffness In Women With Early Stage Breast Cancer, Phase III
Status: Enrolling
Updated:  10/15/2015
Alaska Regional Hospital Cancer Center
mi
from
Anchorage, AK
S0927: Omega-3-Fatty Acid Supplements in Treating Muscle and Bone Pain and Stiffness in Pts W/Stage I, II, or III Breast Cancer Receiving Hormone Therapy
S0927: A Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain and Stiffness In Women With Early Stage Breast Cancer, Phase III
Status: Enrolling
Updated: 10/15/2015
Alaska Regional Hospital Cancer Center
mi
from
Anchorage, AK
Click here to add this to my saved trials
S0927: Omega-3-Fatty Acid Supplements in Treating Muscle and Bone Pain and Stiffness in Pts W/Stage I, II, or III Breast Cancer Receiving Hormone Therapy
S0927: A Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain and Stiffness In Women With Early Stage Breast Cancer, Phase III
Status: Enrolling
Updated:  10/15/2015
Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital
mi
from
Fairbanks, AK
S0927: Omega-3-Fatty Acid Supplements in Treating Muscle and Bone Pain and Stiffness in Pts W/Stage I, II, or III Breast Cancer Receiving Hormone Therapy
S0927: A Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain and Stiffness In Women With Early Stage Breast Cancer, Phase III
Status: Enrolling
Updated: 10/15/2015
Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital
mi
from
Fairbanks, AK
Click here to add this to my saved trials
S0927: Omega-3-Fatty Acid Supplements in Treating Muscle and Bone Pain and Stiffness in Pts W/Stage I, II, or III Breast Cancer Receiving Hormone Therapy
S0927: A Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain and Stiffness In Women With Early Stage Breast Cancer, Phase III
Status: Enrolling
Updated:  10/15/2015
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
S0927: Omega-3-Fatty Acid Supplements in Treating Muscle and Bone Pain and Stiffness in Pts W/Stage I, II, or III Breast Cancer Receiving Hormone Therapy
S0927: A Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain and Stiffness In Women With Early Stage Breast Cancer, Phase III
Status: Enrolling
Updated: 10/15/2015
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
S0927: Omega-3-Fatty Acid Supplements in Treating Muscle and Bone Pain and Stiffness in Pts W/Stage I, II, or III Breast Cancer Receiving Hormone Therapy
S0927: A Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain and Stiffness In Women With Early Stage Breast Cancer, Phase III
Status: Enrolling
Updated:  10/15/2015
Kaiser Permanente Medical Center - Anaheim/Orange County
mi
from
Anaheim, CA
S0927: Omega-3-Fatty Acid Supplements in Treating Muscle and Bone Pain and Stiffness in Pts W/Stage I, II, or III Breast Cancer Receiving Hormone Therapy
S0927: A Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain and Stiffness In Women With Early Stage Breast Cancer, Phase III
Status: Enrolling
Updated: 10/15/2015
Kaiser Permanente Medical Center - Anaheim/Orange County
mi
from
Anaheim, CA
Click here to add this to my saved trials
S0927: Omega-3-Fatty Acid Supplements in Treating Muscle and Bone Pain and Stiffness in Pts W/Stage I, II, or III Breast Cancer Receiving Hormone Therapy
S0927: A Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain and Stiffness In Women With Early Stage Breast Cancer, Phase III
Status: Enrolling
Updated:  10/15/2015
Kaiser Permanente - Deer Valley
mi
from
Antioch, CA
S0927: Omega-3-Fatty Acid Supplements in Treating Muscle and Bone Pain and Stiffness in Pts W/Stage I, II, or III Breast Cancer Receiving Hormone Therapy
S0927: A Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain and Stiffness In Women With Early Stage Breast Cancer, Phase III
Status: Enrolling
Updated: 10/15/2015
Kaiser Permanente - Deer Valley
mi
from
Antioch, CA
Click here to add this to my saved trials